API | haemophilus influenzae type b-neisseria meningitidis serogroups c and y-tetanus-toxoid conjugate vaccine

haemophilus influenzae type b-neisseria meningitidis serogroups c and y-tetanus-toxoid conjugate vaccine Report issue

Vaccine Experimental

AACT MeSH

Active Ingredient History

NOW

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanisms of Action:
- Tetanus toxin (Clostridium tetani (strain Massachusetts / E88)) ^UniProt
Multi-specific: Missing data
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

haemophilus influenzae type b-neisseria meningitidis serogroups c and y-tetanus-toxoid conjugate vaccine | haemophilus influenzae-type b polysaccharide-neisseria meningitidis outer membrane protein conjugate vaccine | hib-menac-tt | hib-mency-tt vaccine | hibmency-tt vaccine | hib-nomp | menhibrix | pedvaxhib | polyribosylribitol phosphate from haemophilus influenzae type b as prp-ompc / outer membrane protein complex of neisseria meningitidis (outer membrane protein complex of the b11 strain of neisseria meningitidis subgroup b) / adsorbed hepatitis b surface antigen produced in recombinant yeast cells (saccharomyces cerevisiae) | prp-ompc

Organizations (4)

Research & Development (4)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (15)

Approved Indications (3)

Haemophilus

Meningitis

Tetanus

Experimental Indications - Clinical Trial Phases 1-4 (13)

Bacterial Infections (Phase 3)

Diphtheria (Phase 3)

Diphtheria-Tetanus-Pertussis Vaccine (Phase 3)

Haemophilus Infections (Phase 4)

Haemophilus influenzae type b (Phase 3)

Hepatitis A virus (Phase 4)

Hepatitis B (Phase 3)

Meningococcal Infections (Phase 3)

Neisseria meningitidis (Phase 3)

Pertussis Vaccine (Phase 3)

Streptococcal Infections (Phase 2)

Tetanus (Phase 3)

Virus Diseases (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 14
# of Trial Organizations: 4

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue